Estudo da eficacia do Nilotinibe Concomitante a Quimioterapia no Tratamento de Pacientes Com Leucemia linfoblastica Aguda Filadelfia Positiva recem-diagnosticada

Trial Profile

Estudo da eficacia do Nilotinibe Concomitante a Quimioterapia no Tratamento de Pacientes Com Leucemia linfoblastica Aguda Filadelfia Positiva recem-diagnosticada

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 15 Jul 2015

At a glance

  • Drugs Nilotinib (Primary)
  • Indications Acute lymphoblastic leukaemia
  • Focus Therapeutic Use
  • Acronyms ANVISA
  • Most Recent Events

    • 08 Jul 2015 Planned End Date changed from 1 Feb 2013 to 1 Jul 2015 as reported by ClinicalTrials.gov record.
    • 03 Jan 2013 Planned end date changed from 1 Apr 2013 to 1 Feb 2013 as reported by ClinicalTrials.gov.
    • 03 Jan 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top